The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients

ConditionHeart Transplantation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-75

SponsorNational Institute of Cardiology, Laranjeiras, Brazil

About this trial

The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.

Eligibility criteria

Qualifiers

capability to understand the objectives of the research and to fulfill the Term of Consent

Disqualifiers

Pregnancy, acute infection diagnosis, use of circulatory assistance devices

Trial design

Treatments tested in this trial

skin microvascular reactivity

Treatment groups

31 Participants

are divided into 1 treatment group

Sponsors and collaborators

National Institute of Cardiology, Laranjeiras, Brazil

Lead sponsor

Source ClinicalTrials.gov